Evidence map›Paper›PMID 29049585›Full record

ArticleJAMA2017

Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.

Anne Z Steiner, David Pritchard, Frank Z Stanczyk, James S Kesner, Juliana W Meadows, Amy H Herring, Donna D Baird

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in JAMA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 178 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
178citing papers in PubMed, 8 pooled it
43.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05298657 unknown statusnot on this mapstarted 2022, after this paper: background citation

The Angiotensin-Melatonin Axis in Poor and Hyper Responders for IVF Treatment

Typeobservational_patient_registrySponsorFatima College of Health SciencesRan2022 to 2024Enrolled200ConditionsPoor Response to Ovulation Induction, PCOS, Endometriosis, Infertility, Female
NCT05743218 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Clinical Study of Liver Meridian in the Treatment of Male Impotence and Female Premature Ovarian Failure

TypeinterventionalSponsorThe First Affiliated Hospital of Hunan University of Traditional Chinese MedicineRan2023 to 2023Enrolled198ConditionsOvarian Reserve, Acupuncture Therapy, MeridianArmselectropuncture
3 · Its place in the literature

Who cites it

178 citing papers in PubMed, 8 syntheses or guidelines pooled it, 392 citations in OpenAlex.

  1. Pooled it
  2. Cancer and fertility management: FIGO best practice advice.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Guideline
  3. Evidence-based guideline: unexplained infertility†.Human reproduction (Oxford, England) · 2023
    Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Fertility planning for women in medicine: a call for an active approach.International journal of women's dermatology · 2026
    Review
  14. Review
  15. Ovarian ageing: from biological constraint to emerging therapeutic frontier.Journal of assisted reproduction and genetics · 2026
    Review
  16. Article
  17. Article
  18. Antioxidants (Basel, Switzerland) · 2026
    Article
  19. Anti-Müllerian hormone and somatic ovarian function: a new perspective.Journal of assisted reproduction and genetics · 2026
    Review
  20. Ovarian reserve testing: assessing oocyte quantity and quality.Journal of assisted reproduction and genetics · 2026
    Review

118 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Anne Z SteinerDepartment of Obstetrics and Gynecology, University of North Carolina, Chapel Hill.
David PritchardDepartment of Biostatistics, University of North Carolina, Chapel Hill.
Frank Z StanczykDepartment of Obstetrics and Gynecology and Preventive Medicine, University of Southern California, Los Angeles.
James S KesnerNational Institute for Occupational Safety and Health, Cincinnati, Ohio.
Juliana W MeadowsNational Institute for Occupational Safety and Health, Cincinnati, Ohio.
Amy H HerringDepartment of Statistical Science, Duke University, Durham, North Carolina.
Donna D BairdEpidemiology Branch, National Institute of Environmental Health Science/National Institutes of Health, Research Triangle Park, North Carolina.
National Institute for Occupational Safety and Health · USUniversity of North Carolina at Chapel Hill · USDuke University · USNational Institute of Environmental Health Sciences · USUniversity of Southern California · US

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Environmental Effects On FertilityZIAES049003 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI BAIRD, DONNA D. · 2009 to 2023
$3.3M
Biomarkers of InfertilityR01HD067683 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STEINER, ANNE ZWEIFEL · 2011 to 2015
$2.7M
Time to ConceiveR21HD060229 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STEINER, ANNE ZWEIFEL · 2009 to 2010
$407k
Intramural CDC HHS CC999999NICHD NIH HHS P2C HD050924NICHD NIH HHS R01 HD067683NICHD NIH HHS R21 HD060229
6 · The paper itself

Abstract

Importance: Despite lack of evidence of their utility, biomarkers of ovarian reserve are being promoted as potential markers of reproductive potential. Objective: To determine the associations between biomarkers of ovarian reserve and reproductive potential among women of late reproductive age. Design, Setting, and Participants: Prospective time-to-pregnancy cohort study (2008 to date of last follow-up in March 2016) of women (N = 981) aged 30 to 44 years without a history of infertility who had been trying to conceive for 3 months or less, recruited from the community in the Raleigh-Durham, North Carolina, area. Exposures: Early-follicular-phase serum level of antimüllerian hormone (AMH), follicle-stimulating hormone (FSH), and inhibin B and urinary level of FSH. Main Outcomes and Measures: The primary outcomes were the cumulative probability of conception by 6 and 12 cycles of attempt and relative fecundability (probability of conception in a given menstrual cycle). Conception was defined as a positive pregnancy test result. Results: A total of 750 women (mean age, 33.3 [SD, 3.2] years; 77% white; 36% overweight or obese) provided a blood and urine sample and were included in the analysis. After adjusting for age, body mass index, race, current smoking status, and recent hormonal contraceptive use, women with low AMH values (<0.7 ng/mL [n = 84]) did not have a significantly different predicted probability of conceiving by 6 cycles of attempt (65%; 95% CI, 50%-75%) compared with women (n = 579) with normal values (62%; 95% CI, 57%-66%) or by 12 cycles of attempt (84% [95% CI, 70%-91%] vs 75% [95% CI, 70%-79%], respectively). Women with high serum FSH values (>10 mIU/mL [n = 83]) did not have a significantly different predicted probability of conceiving after 6 cycles of attempt (63%; 95% CI, 50%-73%) compared with women (n = 654) with normal values (62%; 95% CI, 57%-66%) or after 12 cycles of attempt (82% [95% CI, 70%-89%] vs 75% [95% CI, 70%-78%], respectively). Women with high urinary FSH values (>11.5 mIU/mg creatinine [n = 69]) did not have a significantly different predicted probability of conceiving after 6 cycles of attempt (61%; 95% CI, 46%-74%) compared with women (n = 660) with normal values (62%; 95% CI, 58%-66%) or after 12 cycles of attempt (70% [95% CI, 54%-80%] vs 76% [95% CI, 72%-80%], respectively). Inhibin B levels (n = 737) were not associated with the probability of conceiving in a given cycle (hazard ratio per 1-pg/mL increase, 0.999; 95% CI, 0.997-1.001). Conclusions and Relevance: Among women aged 30 to 44 years without a history of infertility who had been trying to conceive for 3 months or less, biomarkers indicating diminished ovarian reserve compared with normal ovarian reserve were not associated with reduced fertility. These findings do not support the use of urinary or blood follicle-stimulating hormone tests or antimüllerian hormone levels to assess natural fertility for women with these characteristics.

Indexed as

Time-to-PregnancyAdultAnti-Mullerian HormoneBiomarkersFemaleFollicle Stimulating HormoneHumansInfertility, FemaleInhibinsOvarian ReservePregnancyProportional Hazards ModelsProspective StudiesAnti-Mullerian HormoneBiomarkersFollicle Stimulating Hormoneinhibin BInhibins

Identifiers

PMID29049585
PMCPMC5744252
OpenAlexW2761047277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.